Decompressive Surgery in the Treatment of Acute Ischemic Stroke during the First Four Waves of the COVID-19 Pandemic in Germany: A Nationwide Observational Cohort Study

Abstract

Background The COVID-19 pandemic has significantly affected acute ischemic stroke (AIS) care. In this study, we examined the effects of the pandemic on neurosurgical AIS care by means of decompressive surgery (DS).

Methods In this retrospective observational study, we compared the characteristics, in-hospital processes, and in-hospital mortality rates among patients hospitalized for AIS during the first four waves of the pandemic (between January 1, 2020 and October 26, 2021) versus the corresponding periods in 2019 (prepandemic). We used administrative data from a nationwide hospital network in Germany.

Results Of the 177 included AIS cases with DS, 60 were from 2019 and 117 from the first four pandemic waves. Compared with the prepandemic levels, there were no changes in weekly admissions for DS during the pandemic. The same was true for patient age (range: 51.7–60.4 years), the number of female patients (range: 33.3–57.1%), and the prevalence of comorbidity, as measured by the Elixhauser Comorbidity Index (range: 13.2–20.0 points). Also, no alterations were observed in transfer to the intensive care unit (range: 87.0–100%), duration of in-hospital stay (range: 14.6–22.7 days), and in-hospital mortality rates (range: 11.8–55.6%).

Conclusion In Germany, compared with the prepandemic levels, AIS patients undergoing DS during the first four waves of the pandemic showed no changes in demographics, rates of comorbidity, and in-hospital mortality rates. This is in contrast to previous evidence on patients with less critical types of AIS not requiring DS and underlines the uniqueness of the subgroup of AIS patients requiring DS. Our findings suggests that these patients, in contrast to AIS patients in general, were unable to forgo hospitalization during the COVID-19 pandemic. Maintaining the delivery of DS is an essential aspect of AIS care during a pandemic.

Keywords

COVID-19 - acute ischemic stroke - malignant middle cerebral artery infarction - decompressive hemicraniectomy

Publication History

Received: 16 February 2023

Accepted: 14 August 2023

Accepted Manuscript online:
18 August 2023

Article published online:
19 October 2023

• References

• 1 Dengler J, Prass K, Palm F. et al. Changes in nationwide in-hospital stroke care during the first four waves of COVID-19 in Germany. Eur Stroke J 2022; 7 (02) 166-174
• 2 de Havenon A, Ney JP, Callaghan B. et al. Characteristics and outcomes among us patients hospitalized for ischemic stroke before vs during the COVID-19 pandemic. JAMA Netw Open 2021; 4 (05) e2110314
• 3 Ishaque N, Butt AJ, Kamtchum-Tatuene J. et al. Trends in stroke presentations before and during the COVID-19 pandemic: a meta-analysis. J Stroke 2022; 24 (01) 65-78
• 4 Chua AE, Buckley BS, Lapitan MCM, Jamora RDG. Hemicraniectomy for malignant middle cerebral artery infarction (HeMMI): a randomized controlled clinical trial of decompressive hemicraniectomy with standardized medical care versus standardized medical care alone. Acta Med Philipp 2015; 49: 28-33
• 5 Frank JI, Schumm LP, Wroblewski K. et al; HeADDFIRST Trialists. Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial. Stroke 2014; 45 (03) 781-787
• 6 Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB. HAMLET investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009; 8 (04) 326-333
• 7 Jüttler E, Schwab S, Schmiedek P. et al; DESTINY Study Group. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke 2007; 38 (09) 2518-2525
• 8 Jüttler E, Unterberg A, Woitzik J. et al; DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med 2014; 370 (12) 1091-1100
• 9 Slezins J, Keris V, Bricis R. et al. Preliminary results of randomized controlled study on decompressive craniectomy in treatment of malignant middle cerebral artery stroke. Medicina (Kaunas) 2012; 48 (10) 521-524
• 10 Vahedi K, Vicaut E, Mateo J. et al; DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007; 38 (09) 2506-2517
• 11 Zhao J, Su YY, Zhang Y. et al. Decompressive hemicraniectomy in malignant middle cerebral artery infarct: a randomized controlled trial enrolling patients up to 80 years old. Neurocrit Care 2012; 17 (02) 161-171
• 12 Abduljawwad N, Pamnani S, Stoffel M. et al. Effects of the COVID-19 pandemic on spinal fusion procedures for spinal infections in a nationwide hospital network in Germany. J Neurol Surg A Cent Eur Neurosurg 2023; 84 (01) 58-64
• 13 Nachtigall I, Lenga P, Jóźwiak K. et al. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study. Clin Microbiol Infect 2020; 26 (12) 1663-1669
• 14 Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser Comorbidity Index. Med Care 2017; 55 (07) 698-705
• 15 Baayen RH, Davidson DJ, Bates DM. Mixed-effects modeling with crossed random effects for subjects and items. J Mem Lang 2008; 59: 390-412
• 16 Kliegl R, Masson MEJ, Richter EM. A linear mixed model analysis of masked repetition priming. Vis Cogn 2010; 18: 655-681
• 17 Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw 2015; 67: 1-48
• 18 R Core Team. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2020
• 19 Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53 (04) 309-315
• 20 Bor-Seng-Shu E, Figueiredo EG, Amorim RL. et al. Decompressive craniectomy: a meta-analysis of influences on intracranial pressure and cerebral perfusion pressure in the treatment of traumatic brain injury. J Neurosurg 2012; 117 (03) 589-596
• 21 Slotty PJ, Kamp MA, Beez T. et al. The influence of decompressive craniectomy for major stroke on early cerebral perfusion. J Neurosurg 2015; 123 (01) 59-64
• 22 Vedantam A, Robertson CS, Gopinath SP. Quantitative cerebral blood flow using xenon-enhanced CT after decompressive craniectomy in traumatic brain injury. J Neurosurg 2018; 129 (01) 241-246
• 23 Powers WJ, Rabinstein AA, Ackerson T. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50 (12) e344-e418
• 24 Lin J, Frontera JA. decompressive hemicraniectomy for large hemispheric strokes. Stroke 2021; 52 (04) 1500-1510
• 25 Sander C, Dercks NV, Fehrenbach MK. et al. Neurosurgical care during the COVID-19 pandemic in central Germany: a retrospective single center study of the second wave. Int J Environ Res Public Health 2021; 18 (22) 12034
• 26 Falter J, Schebesch KM, Schmidt NO. Declining numbers of neurosurgical emergencies at a German University Medical Center during the coronavirus lockdown. J Neurol Surg A Cent Eur Neurosurg 2022; 83 (04) 314-320